-
Loading metrics
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study
- Alessio Aghemo,
- Marcello Persico,
- Roberta D’Ambrosio,
- Massimo Andreoni,
- Erica Villa,
- Abhi Bhagat,
- Valentina Gallinaro,
- Giuliana Gualberti,
- Rocco Cosimo Damiano Merolla,
- Antonio Gasbarrini

x
- Published: February 2, 2023
- https://doi.org/10.1371/journal.pone.0280165